 |
Iloprost solution for infusion |
|---|---|
| Trade Name | |
| Orphan Indication | Raynaud's phenomenon secondary to systemic sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 1989-09-21 00:00:00 |
| Sponsor | Berlex Laboratories, Inc.;300 Fairfield Road;Wayne, New Jersey, 07470 |
